SAP 14_SF3B14 Activators
SAP 14_SF3B14 activators represent a diverse array of chemicals, each exerting its influence on the activation of SAP 14_SF3B14 through distinct mechanisms. Among these, a notable class includes AMPK activators, with A769662 being a prominent example. A769662 directly engages AMP-activated protein kinase (AMPK), initiating a cascade of events that culminate in the phosphorylation and subsequent activation of SAP 14_SF3B14. This activation is intricately linked to the AMPK-mediated signaling pathway, establishing a direct biochemical connection between the activator and the targeted protein. In addition to direct activators, indirect modulators play a crucial role in influencing SAP 14_SF3B14 activity. Compounds like Niclosamide, BAY 11-7082, and SB203580 operate through distinct cellular pathways to impact SAP 14_SF3B14. Niclosamide, for instance, disrupts the Wnt/β-catenin pathway, alleviating the negative regulation imposed by this pathway on SAP 14_SF3B14. Similarly, BAY 11-7082 targets the NF-κB pathway, while SB203580 acts on the p38 mitogen-activated protein kinase (MAPK) pathway, both indirectly affecting SAP 14_SF3B14 activation. This diversity in chemical activators provides researchers with a comprehensive toolkit for investigating and manipulating SAP 14_SF3B14 activity within cellular contexts.
The intricacies of these chemical modulators extend beyond their individual effects, collectively unveiling a nuanced understanding of the regulatory networks governing SAP 14_SF3B14. By targeting various cellular pathways and molecular processes, these activators serve as valuable tools for scientific inquiry. As researchers delve deeper into the complexities of SAP 14_SF3B14 activation, the knowledge from these chemical activators contributes significantly to unraveling the broader landscape of cellular signaling and protein regulation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
A potent AMP-activated protein kinase (AMPK) activator. A769662 directly activates AMPK, leading to the phosphorylation and activation of SAP 14_SF3B14. The activation occurs through the AMPK-mediated signaling pathway, which positively regulates SAP 14_SF3B14 activity. | ||||||
Niclosamide | 50-65-7 | sc-250564 sc-250564A sc-250564B sc-250564C sc-250564D sc-250564E | 100 mg 1 g 10 g 100 g 1 kg 5 kg | $38.00 $79.00 $188.00 $520.00 $1248.00 $5930.00 | 8 | |
An approved anthelmintic drug. Niclosamide indirectly activates SAP 14_SF3B14 by inhibiting the Wnt/β-catenin pathway, a known negative regulator of SAP 14_SF3B14. Through this inhibition, Niclosamide promotes the expression and activation of SAP 14_SF3B14, enhancing its cellular functions. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
An inhibitor of NF-κB activation. BAY 11-7082 indirectly activates SAP 14_SF3B14 by suppressing the NF-κB pathway. Since SAP 14_SF3B14 is negatively regulated by NF-κB, inhibition of this pathway by BAY 11-7082 results in increased SAP 14_SF3B14 activation, supporting its cellular functions. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A selective inhibitor of p38 MAP kinase. SB203580 indirectly activates SAP 14_SF3B14 by blocking the inhibitory effects of p38 MAP kinase. SAP 14_SF3B14 activity is negatively regulated by p38 MAP kinase, and inhibition of this kinase by SB203580 leads to enhanced SAP 14_SF3B14 activation. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A selective inhibitor of Rho-associated protein kinase (ROCK). Y-27632 indirectly activates SAP 14_SF3B14 by modulating the Rho/ROCK pathway. Inhibition of ROCK by Y-27632 results in the activation of SAP 14_SF3B14, as the Rho/ROCK pathway negatively regulates SAP 14_SF3B14 activity. | ||||||
2-Amino-6-chloro-α-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic Acid Ethyl Ester | 305834-79-1 | sc-479756 | 25 mg | $380.00 | ||
An Akt activator. SC79 directly activates Akt, a kinase that positively regulates SAP 14_SF3B14. Activation of Akt by SC79 leads to the phosphorylation and activation of SAP 14_SF3B14, supporting its cellular functions. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
GSK-3 Inhibitor XVI (CHIR-99021) indirectly activates SAP 14_SF3B14 by inhibiting GSK-3, a negative regulator of SAP 14_SF3B14. Inhibition of GSK-3 by CHIR-99021 results in increased SAP 14_SF3B14 activity, promoting its cellular functions. | ||||||
Troglitazone | 97322-87-7 | sc-200904 sc-200904B sc-200904A | 5 mg 10 mg 25 mg | $110.00 $204.00 $435.00 | 9 | |
A PPARγ agonist. Troglitazone indirectly activates SAP 14_SF3B14 by activating PPARγ, a transcription factor that positively regulates SAP 14_SF3B14. Activation of PPARγ by Troglitazone leads to increased SAP 14_SF3B14 expression and activity, supporting its cellular functions. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
A potent protein phosphatase 1 (PP1) and protein phosphatase 2A (PP2A) inhibitor. Calyculin A directly activates SAP 14_SF3B14 by inhibiting PP1 and PP2A, which are negative regulators of SAP 14_SF3B14. Inhibition of these phosphatases by Calyculin A leads to increased SAP 14_SF3B14 activation. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A selective inhibitor of MEK1 activation. PD 98059 indirectly activates SAP 14_SF3B14 by blocking the inhibitory effects of MEK1. SAP 14_SF3B14 activity is negatively regulated by MEK1, and inhibition of MEK1 by PD 98059 leads to enhanced SAP 14_SF3B14 activation. | ||||||